標(biāo)題: Titlebook: Essential Tuberculosis; Giovanni Battista Migliori,Mario C. Raviglione Textbook 2021 Springer Nature Switzerland AG 2021 MDR-TB and drug r [打印本頁] 作者: 撕成碎片 時間: 2025-3-21 19:01
書目名稱Essential Tuberculosis影響因子(影響力)
作者: justify 時間: 2025-3-21 22:37
http://image.papertrans.cn/e/image/315551.jpg作者: Palate 時間: 2025-3-22 01:40
https://doi.org/10.1007/978-3-030-66703-0MDR-TB and drug resistance; XDR-TB; TB Infection control; TB Control; TB Elimination; Tuberculosis epidem作者: 神圣將軍 時間: 2025-3-22 08:30
https://doi.org/10.1007/978-3-030-53382-3This chapter demonstrates the chest X-ray (CXR) findings expected in active and treated pulmonary tuberculosis (TB) including guidelines in the interpretation of the CXR findings.作者: 地殼 時間: 2025-3-22 09:49 作者: mediocrity 時間: 2025-3-22 16:19 作者: mediocrity 時間: 2025-3-22 18:41 作者: IVORY 時間: 2025-3-23 00:19
Consumer Interests and Economic Wellbeinged slow growing mycobacteria known as the . complex (MTBC). Thanks to recent advances in whole-genome sequencing technologies coupled with analyses of large collections of MTBC isolates from all over the world, several new insights have been achieved, including an improved understanding of the origi作者: 野蠻 時間: 2025-3-23 01:54
https://doi.org/10.1007/978-981-10-1097-2e released from diseased persons, typically through sneezing or coughing. The World Health Organization (WHO) in 2018 estimated 10 million new TB cases worldwide that led to 1.5 million deaths, thus ranking TB as the main cause of mortality from a single pathogen. In this chapter, we briefly describ作者: Rotator-Cuff 時間: 2025-3-23 07:26 作者: Proponent 時間: 2025-3-23 12:14
Consumer Happiness: Multiple Perspectivesctoral strategy needs to be urgently funded and implemented. In this chapter we provide an overview of the principles, pillars, and main indicators of the World Health Organization (WHO)’s End TB Strategy, which is intended to serve as a comprehensive framework for countries to achieve the ambitious作者: 啜泣 時間: 2025-3-23 16:14
https://doi.org/10.1007/978-3-319-19590-2ording to the World Health Organization and approximately 10 million new cases of disease. Since 1921, the vaccine bacille Calmette-Guérin (BCG) has provided partial and variable protection against TB disease. The last 20?years have seen renewed efforts to develop improved, deployable and affordable作者: Resection 時間: 2025-3-23 20:14 作者: 冒號 時間: 2025-3-24 01:08
https://doi.org/10.1007/978-3-658-05105-1revent transmission, particularly in hospitals and other health care facilities as well as in congregate settings..This chapter describes the traditional infection control pillars (administrative, environmental controls and personal respiratory protection measures) and discusses the approaches to li作者: Popcorn 時間: 2025-3-24 03:33 作者: Kidney-Failure 時間: 2025-3-24 08:43
The UNGCP Guidelines: Some Commentse disease in paucibacillary cases and the time needed to report on the sensitivity pattern of the bacteria. We present an overview of the old and newer technologies discussing advantages and limitations.作者: 雇傭兵 時間: 2025-3-24 14:44
Epidemiological Product Assessmenti, and the probability they have to develop resistance to the anti-TB drugs. The bactericidal and sterilizing activity of the available anti-TB drugs is also presented, to define the minimum requirements for an anti-TB regimen and to shed light on the possible future of anti-TB regimens..In the futu作者: 懸崖 時間: 2025-3-24 16:56
https://doi.org/10.1007/978-3-319-90911-0 adverse drug reactions are important to prevent complications. Laboratory testing at baseline and during treatment, in addition to clinical monitoring, is protocolized to improve patient and treatment management. This chapter provides an overview of the most frequent and severe adverse effects caus作者: thwart 時間: 2025-3-24 20:32 作者: Fabric 時間: 2025-3-25 03:12 作者: 消瘦 時間: 2025-3-25 07:11 作者: ALERT 時間: 2025-3-25 11:30 作者: Insul島 時間: 2025-3-25 12:29 作者: CUR 時間: 2025-3-25 18:03 作者: 印第安人 時間: 2025-3-25 20:19 作者: EWER 時間: 2025-3-26 01:09
Consumer Happiness: Multiple Perspectives targets of disease incidence and mortality reduction, as well as elimination of households facing catastrophic costs due to TB. This strategy, conceived for the period 2015–2035, paves the road towards subsequent TB elimination and is fully aligned with the TB-specific indicators of the Sustainable Development Goals (SDGs).作者: 的闡明 時間: 2025-3-26 05:22 作者: CODA 時間: 2025-3-26 10:50
Epidemiological Product Assessmentre of anti-TB regimens we see the possibility, on one side to use new drugs which are presently in the development pipeline, and on the other side to better understand how to use new and repurposed drugs within effective and well-tolerated regimens.作者: nauseate 時間: 2025-3-26 16:41 作者: CANE 時間: 2025-3-26 19:08 作者: 帶來 時間: 2025-3-27 00:40 作者: 后退 時間: 2025-3-27 02:29 作者: 夾死提手勢 時間: 2025-3-27 05:40
cises.This textbook covers the full spectrum of tuberculosis-related topics in a comprehensive yet easy-to-follow, readily accessible format. Filling a significant gap in tuberculosis literature, it addresses tuberculosis?.sensu latu., mirroring the content of the London Queen Mary University tuberc作者: BANAL 時間: 2025-3-27 12:11 作者: 冷淡一切 時間: 2025-3-27 16:43
https://doi.org/10.1007/978-3-319-90911-0g, is protocolized to improve patient and treatment management. This chapter provides an overview of the most frequent and severe adverse effects caused by the first- and second-line drugs used for the treatment of tuberculosis. An approach on how to manage the adverse drugs effects is briefly described.作者: Delude 時間: 2025-3-27 17:56 作者: 形上升才刺激 時間: 2025-3-27 23:30 作者: 親愛 時間: 2025-3-28 04:08 作者: 規(guī)范就好 時間: 2025-3-28 08:42
Textbook 2021lved in tuberculosis management.. .Written by an international and interdisciplinary panel of experts, the book appeals to a broad readership including students, postdoctoral fellows, clinicians, researchers, and nurses, as well as public health officers working in tuberculosis control programs..作者: galley 時間: 2025-3-28 12:39
https://doi.org/10.1007/978-3-658-05105-1evidence guidance is provided as to define the need and requirement for hospital admission and discharge..The chapter includes a ‘questions and answers’ section taking advantages from a recent consensus document of experts published by the WHO European Region..Furthermore, the chapter proposes an exercise for self-learning.作者: jumble 時間: 2025-3-28 16:52
Cliff A. Robb,Russell N. James IIIample ocular and cutaneous TB, and the spectrum of clinical manifestations are described which should prompt a clinician to investigate further. Atypical infection in those with underlying immunosuppression is also explored within this chapter.作者: 陶器 時間: 2025-3-28 22:24 作者: photophobia 時間: 2025-3-29 00:19
Tuberculosis Infection Controlevidence guidance is provided as to define the need and requirement for hospital admission and discharge..The chapter includes a ‘questions and answers’ section taking advantages from a recent consensus document of experts published by the WHO European Region..Furthermore, the chapter proposes an exercise for self-learning.作者: glomeruli 時間: 2025-3-29 06:02 作者: Serenity 時間: 2025-3-29 11:16
Treatment of Drug-Susceptible Tuberculosiside (Z), Ethambutol (E)]. In this chapter, recommendations regarding drug sensitive TB regimens are described, including recommendations about dosage, duration of treatent, and treatment on special situations.作者: Evocative 時間: 2025-3-29 13:04 作者: 書法 時間: 2025-3-29 17:52 作者: 他姓手中拿著 時間: 2025-3-29 21:07
Pathogenesis and Immunology of Tuberculosise released from diseased persons, typically through sneezing or coughing. The World Health Organization (WHO) in 2018 estimated 10 million new TB cases worldwide that led to 1.5 million deaths, thus ranking TB as the main cause of mortality from a single pathogen. In this chapter, we briefly describ作者: epinephrine 時間: 2025-3-30 01:13 作者: set598 時間: 2025-3-30 06:48
Tuberculosis: WHO-Recommended Strategies and Global Health Perspectivesctoral strategy needs to be urgently funded and implemented. In this chapter we provide an overview of the principles, pillars, and main indicators of the World Health Organization (WHO)’s End TB Strategy, which is intended to serve as a comprehensive framework for countries to achieve the ambitious作者: 高調(diào) 時間: 2025-3-30 09:13
Tuberculosis Vaccinesording to the World Health Organization and approximately 10 million new cases of disease. Since 1921, the vaccine bacille Calmette-Guérin (BCG) has provided partial and variable protection against TB disease. The last 20?years have seen renewed efforts to develop improved, deployable and affordable作者: Talkative 時間: 2025-3-30 14:50
Latent Tuberculosis Infection Diagnosis and Treatmentable immunological diagnostic tests, as well as LTBI treatment, referring to the best available evidence and international guidance. It then reviews the evidence for use of LTBI testing and treatment in different settings and populations and discusses the trade-offs between an individual risk-based 作者: 云狀 時間: 2025-3-30 16:35 作者: faultfinder 時間: 2025-3-30 22:41
Tuberculosis Clinical Presentation and Differential Diagnosison symptoms and signs of active TB in the lung and extra-pulmonary sites. The sites of disease explored include: pulmonary infections, lymph node disease and central nervous system disease amongst others. Possible differential diagnoses to be considered are discussed within each organ, though often 作者: CAGE 時間: 2025-3-31 03:01 作者: 無王時期, 時間: 2025-3-31 06:35
Rationale for Anti-Tuberculosis Chemotherapyi, and the probability they have to develop resistance to the anti-TB drugs. The bactericidal and sterilizing activity of the available anti-TB drugs is also presented, to define the minimum requirements for an anti-TB regimen and to shed light on the possible future of anti-TB regimens..In the futu作者: CRP743 時間: 2025-3-31 09:10
